Speaking of wellness meds…SSRIs could be taking a toll on young people’s developing sexuality. Antidepressant prescriptions for teens climbed 69% between 2016 and 2022, with 22% of college students taking antidepressants in 2023-24 (up from 8% in 2007). But a New York Times investigation found there’s no dedicated research on how these drugs affect adolescents during the critical period when sexuality naturally develops. Adults on SSRIs experience negative sexual side effects 30-80% of the time, but most prescribers don’t mention this during informed consent, citing concerns about “patient compliance.” The concern is that these effects can last years even after someone stops taking the medication, a condition called PSSD (post-SSRI sexual dysfunction). To some, the silence around how these medications might alter other parts of teens and young adults’ development raises questions about what’s being traded for mental health support. (NYT)
Reports and Webinars are limited to the Region terms of your Pro and Prime subscription, as shown in “Purchased Regions”.
- To filter all content types to individual Region(s) you have purchased, apply your Region(s) under “Purchased Regions.”
Articles, Video Updates, and News across all Regions are open to all Pro and Prime subscribers.
- To see this content for any Region, use the “Content Filter”.
